These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34078109)

  • 1. Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.
    Kelly DM; Ademi Z; Doehner W; Lip GYH; Mark P; Toyoda K; Wong CX; Sarnak M; Cheung M; Herzog CA; Johansen KL; Reinecke H; Sood MM
    Stroke; 2021 Jul; 52(7):e328-e346. PubMed ID: 34078109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Johansen KL; Garimella PS; Hicks CW; Kalra PA; Kelly DM; Martens S; Matsushita K; Sarafidis P; Sood MM; Herzog CA; Cheung M; Jadoul M; Winkelmayer WC; Reinecke H;
    Kidney Int; 2021 Jul; 100(1):35-48. PubMed ID: 33961868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke and cerebrovascular diseases in patients with chronic kidney disease.
    Toyoda K; Ninomiya T
    Lancet Neurol; 2014 Aug; 13(8):823-33. PubMed ID: 25030514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disentangling the multiple links between renal dysfunction and cerebrovascular disease.
    Kelly D; Rothwell PM
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):88-97. PubMed ID: 31511306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.
    Sarnak MJ; Amann K; Bangalore S; Cavalcante JL; Charytan DM; Craig JC; Gill JS; Hlatky MA; Jardine AG; Landmesser U; Newby LK; Herzog CA; Cheung M; Wheeler DC; Winkelmayer WC; Marwick TH;
    J Am Coll Cardiol; 2019 Oct; 74(14):1823-1838. PubMed ID: 31582143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal-Cerebral Pathophysiology: The Interplay Between Chronic Kidney Disease and Cerebrovascular Disease.
    Hanna RM; Ferrey A; Rhee CM; Kalantar-Zadeh K
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105461. PubMed ID: 33199089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Turakhia MP; Blankestijn PJ; Carrero JJ; Clase CM; Deo R; Herzog CA; Kasner SE; Passman RS; Pecoits-Filho R; Reinecke H; Shroff GR; Zareba W; Cheung M; Wheeler DC; Winkelmayer WC; Wanner C;
    Eur Heart J; 2018 Jun; 39(24):2314-2325. PubMed ID: 29522134
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    House AA; Wanner C; Sarnak MJ; Piña IL; McIntyre CW; Komenda P; Kasiske BL; Deswal A; deFilippi CR; Cleland JGF; Anker SD; Herzog CA; Cheung M; Wheeler DC; Winkelmayer WC; McCullough PA;
    Kidney Int; 2019 Jun; 95(6):1304-1317. PubMed ID: 31053387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Kidney Disease is a Risk Factor for Stroke.
    Wyld M; Webster AC
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105730. PubMed ID: 33926795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Eckardt KU; Bansal N; Coresh J; Evans M; Grams ME; Herzog CA; James MT; Heerspink HJL; Pollock CA; Stevens PE; Tamura MK; Tonelli MA; Wheeler DC; Winkelmayer WC; Cheung M; Hemmelgarn BR;
    Kidney Int; 2018 Jun; 93(6):1281-1292. PubMed ID: 29656903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing the proclamation of stroke and potentially preventable dementias.
    Hachinski V; Ganten D; Lackland D; Kreutz R; Tsioufis K; Hacke W;
    J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1354-1359. PubMed ID: 30298973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Tonelli M; Karumanchi SA; Thadhani R
    Circulation; 2016 Feb; 133(5):518-36. PubMed ID: 26831434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.
    Dad T; Weiner DE
    Semin Nephrol; 2015 Jul; 35(4):311-22. PubMed ID: 26355250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation.
    Małyszko J; Bamias A; Danesh FR; Dębska-Ślizień A; Gallieni M; Gertz MA; Kielstein JT; Tesarova P; Wong G; Cheung M; Wheeler DC; Winkelmayer WC; Porta C;
    Kidney Int; 2020 Dec; 98(6):1407-1418. PubMed ID: 33276867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of cerebrovascular diseases in dialysis patients.
    Naganuma T; Takemoto Y
    Contrib Nephrol; 2015; 185():138-46. PubMed ID: 26023023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.
    Davison SN; Levin A; Moss AH; Jha V; Brown EA; Brennan F; Murtagh FE; Naicker S; Germain MJ; O'Donoghue DJ; Morton RL; Obrador GT;
    Kidney Int; 2015 Sep; 88(3):447-59. PubMed ID: 25923985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV; Cheung M; Wheeler DC; Winkelmayer WC; Mann JFE;
    Kidney Int; 2019 May; 95(5):1027-1036. PubMed ID: 31010478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines.
    Kelly DM; Rothwell PM
    Kidney Int; 2020 Feb; 97(2):266-278. PubMed ID: 31866114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Chan CT; Blankestijn PJ; Dember LM; Gallieni M; Harris DCH; Lok CE; Mehrotra R; Stevens PE; Wang AY; Cheung M; Wheeler DC; Winkelmayer WC; Pollock CA;
    Kidney Int; 2019 Jul; 96(1):37-47. PubMed ID: 30987837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Marwick TH; Amann K; Bangalore S; Cavalcante JL; Charytan DM; Craig JC; Gill JS; Hlatky MA; Jardine AG; Landmesser U; Newby LK; Herzog CA; Cheung M; Wheeler DC; Winkelmayer WC; Sarnak MJ;
    Kidney Int; 2019 Oct; 96(4):836-849. PubMed ID: 31543156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.